Morgan Stanley Downgrades Definitive Healthcare to Equal-Weight, Lowers Price Target to $9
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Craig Hettenbach downgraded Definitive Healthcare (DH) from Overweight to Equal-Weight and reduced the price target from $11.5 to $9.

May 08, 2024 | 9:42 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Morgan Stanley downgraded Definitive Healthcare from Overweight to Equal-Weight and lowered the price target from $11.5 to $9.
The downgrade by Morgan Stanley from Overweight to Equal-Weight, accompanied by a reduction in the price target, suggests a less optimistic outlook on DH's stock performance in the short term. This could lead to a negative sentiment among investors, potentially causing a decrease in the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100